Midazolam (Versed®) Side Effects

Dr. Sheridan Walter
Dr. Jennie Stanford
Written by Dr. Sheridan Walter on 28 May 2025
Medically reviewed by Dr. Jennie Stanford on 28 May 2025

Midazolam, sold under the brand name Versed® in the U.S., is a short-acting benzodiazepine frequently used before or during medical procedures to reduce anxiety and induce sedation. It amplifies key inhibitory signals in the central nervous system (CNS), causing sedative and calming effects.

However, if misused or combined with certain medications, midazolam side effects can range from mild drowsiness and brief confusion to serious breathing problems.

Key takeaways:
  • Midazolam’s amnestic properties prevent patients from remembering unpleasant procedures.
  • Side effects vary, from mild fatigue to potentially severe respiratory depression.
  • Long-term or unsupervised use can trigger dependence and withdrawal, requiring tapering over weeks.
a woman in bed experiencing dizziness and headaches as a side effect of Midazolam (Versed®)

How does midazolam work?

Understanding how Versed® affects the brain helps explain its benefits and risks. Midazolam is a benzodiazepine that binds to gamma-aminobutyric acid (GABA) receptors, the primary inhibitory neurotransmitter in the brain. GABA naturally slows nerve impulses; by binding to GABA-A receptors, midazolam amplifies this effect, producing sedation, lowering anxiety, and causing short-term memory loss.

Unlike longer-acting benzodiazepines, midazolam has a short half-life, which often allows patients to recover more quickly from procedural sedation. Still, how a person metabolizes midazolam depends on organ functions (liver and kidneys), age, other medical conditions, and concurrent medications. When midazolam is combined with opioids, alcohol, or other central nervous system depressants, risky sedation can occur.

When administering midazolam, healthcare providers typically monitor respiration (breathing), oxygen saturation (the percentage of oxygen carrying capacity of the blood), blood pressure, and heart rate for the onset of midazolam side effects.

Common midazolam side effects

Mild-to-moderate side effects occur for a significant portion of people receiving midazolam. They typically resolve once the medication wears off.

  • Drowsiness and fatigue: Because Versed® suppresses CNS activity, sedation may linger for a few hours, making it unsafe to drive or operate machinery soon afterward.
  • Dizziness and lightheadedness: Changing positions quickly (e.g., standing up) can spur feelings of imbalance or lightheadedness, especially in older adults.
  • Short-term memory gaps: Patients sometimes cannot recall events that occur while under the influence of midazolam.
  • Headaches: Mild headaches occasionally arise once sedation wears off.
  • Nausea: Some people notice gastrointestinal problems, particularly when midazolam is used with opioid pain relievers or taken on an empty stomach.
  • Blurred vision: Transient vision changes may occur, but they usually resolve as the drug’s half-life elapses.

The following additional side effects are reported after IV administration:

  • Pain during injection and at the injection site
  • Induration at the injection site
  • Hiccups
  • Vomiting
  • Coughing
  • Diplopia

These common side effects usually do not call for medical intervention. Rest, gradual return to activities, and adequate hydration help address temporary discomfort. However, if symptoms intensify or last longer than expected, seeking medical guidance is prudent.

Severe side effects

Although midazolam (Versed®) is recognized as safe under professional supervision, specific serious side effects remain inevitable:

  • Respiratory depression: Breathing can slow, causing dangerously low oxygen intake.
  • Paradoxical reactions: Rather than sedation, a small percentage of people given Versed® experience agitation, restlessness, or even aggression.
  • Significant drops in blood pressure: People given midazolam may experience hypotension, causing sudden dizziness or fainting.
  • Arrhythmias: Although uncommon, abnormal heart rhythms may emerge in susceptible patients taking/given Versed®, particularly those with existing heart problems.
  • Psychiatric side effects: People who are given midazolam may experience euphoria, emergence delirium, paresthesia, confusion, disorientation, emotional and mood disturbances, hallucinations, and dysphoria.
  • Allergic reactions: Signs (like swelling of the throat or lips, hives, or labored breathing) may signal an acute allergy following Versed® administration and require urgent medical care.

What to do when experiencing severe symptoms

Immediate medical attention is paramount when someone displays extreme drowsiness, slow or shallow breathing, severe confusion, or suspected allergy after midazolam use. Healthcare providers can administer oxygen, IV fluids, or even a benzodiazepine-reversal agent (flumazenil) to counteract excessive sedation.

Risks and complications

Various factors can intensify midazolam side effects and lead to worse or altered outcomes.

Medication interactions

  • Azole antifungals, like ketoconazole
  • Macrolide antibiotics, like erythromycin
  • Certain antiretroviral agents
  • Co-administration of midazolam with sedative/hypnotic agents: alcohol, opioids, antipsychotics, other benzodiazepines (diazepam, lorazepam, or alprazolam), barbiturates, propofol, ketamine, precedex, antihistamines, and centrally acting antihypertensives (clonidine, guanfacine, methyldopa, and moxonidine).

Contraindications and precautions

  • Liver or kidney impairment.
  • Hypersensitivity or allergy to midazolam.
  • Acute angle-closure glaucoma.
  • Hypotension and shock.
  • Pre-existing breathing problems: Asthma, chronic obstructive pulmonary disease (COPD), or sleep apnea can increase vulnerability to respiratory depression.
  • Older adults: Because geriatric patients metabolize drugs more slowly, lower doses may be necessary to avoid confusion, falls, or extended sedation.

Long-term complications

Midazolam abuse and dependence

Midazolam’s appeal lies in its speed of onset—it offers a rapid, calming rush followed by a quick offset. That same pharmacokinetic profile invites redosing and tolerance within days, particularly when the drug is taken outside short-procedure settings.  

Some people chase the brief amnesic “black-out” effect as a form of escapism, or they may inject oral/IV formulations for a faster high. As tolerance rises, physical dependence often develops, and the withdrawal cluster (rebound anxiety, tremor, perceptual distortion, and potentially seizures) can appear within hours of a missed dose.

There are some indicators of midazolam misuse:

  • Escalating the dose or taking extra add-on doses sooner than prescribed.
  • Mixing midazolam with alcohol, opioids, or other gabaminergic sedatives to deepen the dissociative effect.
  • Acute distress or agitation when a dose is delayed.
  • “Doctor shopping” or sourcing veterinary or illicit midazolam to bridge gaps in supply.
  • Injecting midazolam without medical supervision.

Midazolam withdrawal and tapering

Abruptly stopping midazolam, especially after prolonged use, IV use, or use of high doses, can cause withdrawal symptoms, including increased anxiety, tremors, insomnia, and (in severe cases) seizures.

A structured tapering protocol, where the midazolam dose is incrementally lowered over a set period, reduces midazolam withdrawal symptoms. One tapering schedule is the cut and hold method, in which the dosage of midazolam is reduced by 5–10% every 2–4 weeks, and each dose is maintained until symptoms are stable. Tapering midazolam may take up to a few months for some patients.  

Sometimes doctors switch to a long-acting benzodiazepine (like diazepam) before tapering down further, ensuring more stable blood levels throughout the process.  

Supportive measures, such as counseling or cognitive-behavioral therapy (CBT), while tapering help address the psychological aspects of withdrawal and help patients build healthier strategies to manage anxiety or insomnia without relying on benzodiazepines.

Final thoughts

Midazolam’s short duration of action and sedative properties make it a valuable tool for inpatient and outpatient procedures that require sedation, sparing patients intense anxiety or distress. At the same time, midazolam side effects range from short-lived drowsiness and memory lapses to severe complications, like respiratory depression or paradoxical reactions.

Transparency surrounding medical history, adherence to recommended dosages, appropriate usage, and awareness of potential misuse are essential to safely harnessing the benefits of midazolam.

For those who develop dependence, supervised tapering with concurrent mental health support offers the safest path forward.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Corôa, M. C. P., Mendes, P. F. S., Baia-da-Silva, D. C., Souza-Monteiro, D., Ferreira, M. K. M., Braga, G. L. C., Damasceno, T. V., Perdigão, J. M., & Lima, R. R. (2022). What is known about midazolam? A bibliometric approach of the literature. Healthcare (Basel, Switzerland), 11(1), 96.
  2. Prommer E. (2020). Midazolam: an essential palliative care drug. Palliative care and social practice, 14, 2632352419895527.
  3. Kensche, M., Sander, J. W., & Sisodiya, S. M. (2010). Significant hypotension following buccal midazolam administration. BMJ case reports, 2010, bcr0920103371.
  4. Saiso, K., Adnonla, P., Munsil, J., Apipan, B., Rummasak, D., & Wongsirichat, N. (2017). Complications associated with intravenous midazolam and fentanyl sedation in patients undergoing minor oral surgery. Journal of dental anesthesia and pain medicine, 17(3), 199–204.
  5. Gonzalez Castro, L. N., Mehta, J. H., Brayanov, J. B., & Mullen, G. J. (2017). Quantification of respiratory depression during pre-operative administration of midazolam using a non-invasive respiratory volume monitor. PloS one, 12(2), e0172750.
  6. Cabrera, L. S., Santana, A. S., Robaina, P. E., & Palacios, M. S. (2010). Paradoxical reaction to midazolam reversed with flumazenil. Journal of Emergencies, Trauma and Shock, 3(3), 307.
  7. Choi, Y. F., Wong, T. W., & Lau, C. C. (2004). Midazolam is more likely to cause hypotension than etomidate in emergency department rapid sequence intubation. Emergency medicine journal: EMJ, 21(6), 700–702.
  8. Rodrigo, C. R., Rosenquist, J. B., & Cheng, C. H. (1990). Cardiac Dysrhythmias With Midazolam Sedation. Anesthesia Progress, 37(1), 20.
  9. Cleveland Clinic. (2025). Midazolam injection (Versed): Uses & side effects. Retrieved May 10, 2025 from
  10. Whitehouse, T., Snelson, C., Grounds, M., Willson, J., Tulloch, L., Linhartova, L., Shah, A., Pierson, R., & England, K. (2014, June). Sedation for patients in ICU: Intensive Care Society review of best practice for analgesia and sedation in critical care. Intensive Care Society.
  11. Morita, T., Tei, Y., & Inoue, S. (2003). Correlation of the Dose of Midazolam for Symptom Control with Administration Periods: The Possibility of Tolerance. Journal of Pain and Symptom Management, 25(4), 369–375.
  12. Ramazani, Y., Nemati, A., Moshiri, M., Talebi, M., Dadkhah, M., & Etemad, L. (2024). Treatment of high dose of intravenous midazolam abuse: a case report. International clinical psychopharmacology, 39(3), 206–210.
  13. Kerr, T., Kiatying-Angsulee, N., Fairbairn, N., Hayashi, K., Suwannawong, P., Kaplan, K., Lai, C., & Wood, E. (2010). High rates of midazolam injection among drug users in Bangkok, Thailand. Harm reduction journal, 7, 7.
  14. Mets, B., & Worthington, M. (1991). Midazolam-induced benzodiazepine withdrawal syndrome. Anaesthesia, 46(8), 686–688.
  15. U.S. Food and Drug Administration. (2016, August 31). FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning [Drug Safety Communication]. Retrieved May 10, 2025 from
  16. Benzodiazepine Information Coalition. (2023, May 16). Benzodiazepine tapering strategies and solutions. Retrieved May 10, 2025 from

Activity History - Last updated: 28 May 2025, Published date:


Reviewer

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Jennie Stanford, MD, FAAFP, DipABOM is a dual board-certified physician in both family medicine and obesity medicine. She has a wide range of clinical experiences, ranging from years of traditional clinic practice to hospitalist care to performing peer quality review to ensure optimal patient care.

Activity History - Medically Reviewed on 27 May 2025 and last checked on 28 May 2025

Medically reviewed by
Dr. Jennie Stanford

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (833) 840-1202
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org

Related topics

Valium (Diazepam)

7 minutes read